Managing uninvestigated dyspepsia in primary care
- PMID: 18310261
- PMCID: PMC2270980
- DOI: 10.1136/bmj.39497.622720.80
Managing uninvestigated dyspepsia in primary care
Abstract
Test and treat for Helicobacter pylori is still as good as proton pump inhibitors first
Conflict of interest statement
Competing interests: NC has received honoraria from Abbott, Astra-Zeneca, Janssen, and Nycomed for giving talks about proton pump inhibitor and dyspepsia. NC has also received research support from Astra-Zeneca.
Comment on
-
Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial).BMJ. 2008 Mar 22;336(7645):651-4. doi: 10.1136/bmj.39479.640486.AE. Epub 2008 Feb 29. BMJ. 2008. PMID: 18310262 Free PMC article. Clinical Trial.
References
-
- Chiba N, Veldhuyzen van Zanten SJO, Sinclair P, Ferguson RA, Escobedo S, Grace E. Treatment of H pylori infection in primary care patients with uninvestigated dyspepsia improves symptoms: the CADET-Hp (Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive) randomised controlled trial. BMJ 2001;324:1012-6. - PMC - PubMed
-
- Veldhuyzen van Zanten SJ, Chiba N, Armstrong D, Barkun A, Thomson A, Smyth S, et al. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in Helicobacter pylori negative, primary care patients with dyspepsia: The CADET-HN study. Am J Gastroenterol 2005;100:1477-88. - PubMed
-
- Armstrong D, Veldhuyzen van Zanten SJ, Barkun AN, Chiba N, Thomson AB, Smyth S, et al. Heartburn-dominant, uninvestigated dyspepsia: a comparison of “PPI-start” and “H2-RA-start” management strategies in primary care—the CADET-HR study. Aliment Pharmacol Ther 2005;21:1189-202. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical